SCHEMBL1462968

SCHEMBL1462968

CC(C)c1ccc(C(Cl)Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
TYR P14679 2/20 0.46
HTT P42858 2/20 0.42
ADRB2 P07550 1/20 0.42
IDO1 P14902 2/20 0.41
NFKB1 P19838 1/20 0.40
MGLL Q99685 1/20 0.39
LMNA P02545 1/20 0.39
CYP2C9 P11712 3/20 0.38
HIF1A Q16665 3/20 0.38
CYP2D6 P10635 1/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
TRPA1 O75762 1/20 0.37
PTGS1 P23219 1/20 0.37
CACNA1C Q13936 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496691 0.97 TSHR (0.48) TSHRTYRHTTADRB2IDO1
SCHEMBL3184041 0.97 TSHR (0.48) TSHRTYRHTTADRB2IDO1
SCHEMBL104124 0.83 TYR (0.58) TYRHTTADRB2IDO1NFKB1
SCHEMBL5075045 0.83 TSHR (0.67) TSHRADRB2LMNAHIF1AMAPK1
SCHEMBL8750387 0.81 TYR (0.46) TSHRTYRHTTADRB2IDO1
SCHEMBL30471741 0.81 TYR (0.46) TSHRTYRHTTADRB2IDO1
Ammonia Solution, Strong SCHEMBL7550588 0.79 TYR (0.55) TYRHTTADRB2IDO1NFKB1
SCHEMBL28912214 0.79 TYR (0.55) TYRHTTADRB2IDO1NFKB1
Water SCHEMBL11726962 0.79 TYR (0.55) TYRHTTADRB2IDO1NFKB1
Hydrochloric Acid SCHEMBL11505822 0.79 TSHR (0.62) TSHRADRB2IDO1LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018158674-A1 ASYMMETRIC SYNTHESIS OF (S)-3-(1-(DIMETHYLAMINO) ETHYL) PHENYLETHYL(METHYL)CARBAMATE AND ITS SALTS TROY LIFE SCIENCES (IN) 2018-09-07 WO claimed
US-8921561-B2 One-pot preparation of hexahydroisoquinolines from amides MALLINCKRODT LLC (US) 2014-12-30 US claimed
US-20130137874-A1 One-Pot Preparation of Hexahydroisoquinolines from Amides MALLINCKRODT LLC (US) 2013-05-30 US claimed
US-8431705-B2 One-pot preparation of hexahydroisoquinolines from amides MALLINCKRODT LLC (US) 2013-04-30 US claimed
WO-2012096824-A1 PHENYLGLYOXYLIC ACID DERIVATIVES AND THEIR PREPARATION AND USE TRANSTECH PHARMA, INC. (US) 2012-07-19 WO claimed
WO-2011038172-A1 ONE-POT PREPARATION OF HEXAHYDROISOQUINOLINES FROM DIHYDROISOQUINOLINES MALLINCKRODT INC. (US) 2011-03-31 WO claimed
WO-2011038169-A2 ONE-POT PREPARATION OF HEXAHYDROISOQUINOLINES FROM AMIDES MALLINCKRODT INC. (US) 2011-03-31 WO claimed
US-20110071300-A1 One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines MALLINCKRODT INC. (US) 2011-03-24 US claimed
US-20110071299-A1 One-Pot Preparation of Hexahydroisoquinolines from Amides MALLINCKRODT INC. (US) 2011-03-24 US claimed
US-20240059710-A1 KRAS G12D Inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-02-22 US disclosed
US-20240025918-A1 KRAS G12D Inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-01-25 US disclosed
CN-114029091-B Dual ligand catalytic system for ethylene selective trimerization, preparation method and application thereof 浙江智英石化技术有限公司 2024-01-16 CN disclosed
WO-2023056951-A1 ARYL-SUBSTITUTED HETEROCYCLIC COMPOUND 杭州德睿智药科技有限公司 2023-04-13 WO disclosed
US-20230081426-A1 COMPOUNDS AND METHODS FOR KRAS MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. 2023-03-16 US disclosed
US-20070032664-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide BUTLER DONALD E 2007-02-08 US disclosed
EP-1734034-A2 Carboxylic acid salts of beta-alanine esters or -amides Warner-Lambert Company LLC (US) 2006-12-20 EP disclosed
EP-1728785-A1 7-[(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-heptanoic acid ester 3,5-dioxo-acetal Warner-Lambert Company LLC (US) 2006-12-06 EP disclosed
EP-1724256-A2 Novel process for the synthesis of 5-(4-fluorphenyl)-1-2(2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide Warner-Lambert Company LLC (US) 2006-11-22 EP disclosed
US-20050239869-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1eta-pyrrole-3-carboxylic acid phenylamide BUTLER DONALD E 2005-10-27 US disclosed
US-20020133026-A1 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE BUTLER DONALD EUGENE (US) 2002-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059710-A1 KRAS G12D Inhibitors KRAS, NRAS, HRAS TSHR 3828/4885TYR 4685/4885HTT 3094/4885
US-20110071299-A1 One-Pot Preparation of Hexahydroisoquinolines from Amides QARS1, QTRT1, SFPQ TSHR 1956/4885TYR 588/4885HTT 102/4885
US-20230081426-A1 COMPOUNDS AND METHODS FOR KRAS MODULATION AND INDICATIONS THEREFOR KRAS, NRAS, HRAS TSHR 1685/4885TYR 3593/4885HTT 1337/4885
US-20050239869-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1eta-pyrrole-3-carboxylic acid phenylamide PAH, PCCA, HPD TSHR 2998/4885TYR 322/4885HTT 951/4885
US-20020133026-A1 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE PCCA, PAH, HPD TSHR 3366/4885TYR 520/4885HTT 1419/4885
US-20070032664-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide PAH, PCCA, HPD TSHR 3413/4885TYR 473/4885HTT 1435/4885
US-20130137874-A1 One-Pot Preparation of Hexahydroisoquinolines from Amides QARS1, QTRT1, SFPQ TSHR 1956/4885TYR 588/4885HTT 102/4885
US-20110071300-A1 One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines QDPR, QTRT1, DHPS TSHR 3399/4885TYR 456/4885HTT 50/4885
US-20240025918-A1 KRAS G12D Inhibitors KRAS, NRAS, HRAS TSHR 4206/4885TYR 4485/4885HTT 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.